BIOLIFE SOLUTIONS
(NASDAQ: BLFS)

BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing hypothermic storage and cryopreservation solutions for cells and tissue. The Company�s product offerings include biopreservation media products for cells, tissues, and organs; generic formulations of blood stem cell freezing media products; custom product formulation and custom packaging services; precision thermal packaging products and C=contract aseptic manufacturing formulation, fill, and finish services of liquid media products. The Company markets it�s HypoThermosol, CryoStor, generic BloodStor, SAVSU biopreservation media products and precision thermal packaging products to the biobanking, drug discovery, and regenerative medicine markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant centers, and suppliers of cells to the drug discovery, toxicology testing and diagnostic markets.

23.880

+0.480 (+2.05%)
Range 23.610 - 24.330   (3.05%)
Open 23.640
Previous Close 23.400
Bid Price 21.620
Bid Volume 10
Ask Price 21.870
Ask Volume 12
Volume 80,769
Value -
Remark
Delayed prices. Updated at 02 Nov 2024 02:12.
Data powered by
View All Events

About BIOLIFE SOLUTIONS INC

BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing hypothermic storage and cryopreservation solutions for cells and tissue. The Company�s product offerings include biopreservation media products for cells, tissues, and organs; generic formulations of blood stem cell freezing media products; custom product formulation and custom packaging services; precision thermal packaging products and C=contract aseptic manufacturing formulation, fill, and finish services of liquid media products. The Company markets it�s HypoThermosol, CryoStor, generic BloodStor, SAVSU biopreservation media products and precision thermal packaging products to the biobanking, drug discovery, and regenerative medicine markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant centers, and suppliers of cells to the drug discovery, toxicology testing and diagnostic markets.

Loading Chart...

Please login to view stock data and analysis